All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 21, 2023
Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
Dermatologic RSS Feed RSS

Avita effective for acne, less irritating

May 10, 1996
No Comments

Selectin inhibitor GSC-150 effective in dermatitis models

May 3, 1996
No Comments

Xoma, Genentech to collaborate on anti-CD11a

May 3, 1996
No Comments

Dermatology drugs in the BMS pipeline

April 26, 1996
No Comments

Hyal-CT1101 effective in phase III trial

April 26, 1996
No Comments

Iamin gel in phase I in Japan

April 26, 1996
No Comments

Teva's generic minoxidil approved in U.S.

April 19, 1996
No Comments

Azelex now available to treat acne

April 12, 1996
No Comments

ALA-PDT to be studied for hair removal

April 12, 1996
No Comments

Silkis licensed to Galderma

April 12, 1996
No Comments
Previous 1 2 … 396 397 398 399 400 401 402 403 404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 20, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for March 20, 2022.
  • Woman with headache

    Nasal spray Zavzpret cleared, Pfizer showing ‘growth on every measure’ in migraine

    BioWorld
    Pricing won’t be known until later for Pfizer Inc.’s Zavzpret (zavegepant), which became the first and only calcitonin gene-related peptide receptor antagonist...
  • Lungs

    Affibody in $637M respiratory disease deal with Chiesi

    BioWorld
    Chiesi Farmaceutici SpA has agreed to pay Affibody AB up to $214 million in a collaboration and licensing agreement to develop an inhaled treatment for...
  • Women handshake with virology graphics

    Modex codex may read out new story in EBV with Merck vaccine pact worth $922M-plus

    BioWorld
    Another step forward in the quest for an Epstein-Barr virus (EBV) vaccine took the form of Merck & Co. Inc.’s deal with Modex Therapeutics Inc., owned by Opko...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing